Literature DB >> 17981779

EpCAM expression in normal, non-pathological tissues.

Eva Schmelzer1, Lola M Reid.   

Abstract

Epithelial Cell Adhesion Molecule (EpCAM) is a transmembrane glycoprotein that is associated with various cancers. Most normal, non-pathological epithelial tissue is EpCAM positive with the exception of epidermal keratinocytes, gastric parietal cells, myoepithelial cells, thymic cortical epithelial, and hepatocytes. However, during early liver development EpCAM expression is also observed. In our studies, we have demonstrated that EpCAM is expressed in non-pathological human livers on hepatic progenitors in livers of all donor ages, from 16 weeks gestation fetal livers to adult. Hepatic progenitors of the liver consist of the stem cells and their descendants, the hepatoblasts, that give rise to the hepatocytic and biliary lineages. Both hepatic stem cells and most hepatoblasts express EpCAM, but only hepatoblasts are alpha-fetoprotein positive. The percentage of EpCAM positive progenitors in human livers varies with donor age and is about 2.5% in the adult and 12.1% in fetuses. In vivo, hepatic stem cells have been found associated with the canals of Hering. Xeno-transplantation experiments with EpCAM positive human liver cells have revealed their potential for proliferation and differentiation to mature liver parenchymal cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17981779     DOI: 10.2741/2911

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  42 in total

1.  Perinodular ductular reaction/epithelial cell adhesion molecule loss in small hepatic nodules.

Authors:  Qin Zhang; Chuan-Shan Zhang; Qi Xin; Zhe Ma; Gui-Qiu Liu; Bing-Bing Liu; Feng-Mei Wang; Ying-Tang Gao; Zhi Du
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  In situ labeling and magnetic resonance imaging of transplanted human hepatic stem cells.

Authors:  Randall McClelland; Eliane Wauthier; Tommi Tallheden; Lola M Reid; Edward Hsu
Journal:  Mol Imaging Biol       Date:  2011-10       Impact factor: 3.488

Review 3.  Clinical implications of cancer stem cell biology in hepatocellular carcinoma.

Authors:  Junfang Ji; Xin Wei Wang
Journal:  Semin Oncol       Date:  2012-08       Impact factor: 4.929

Review 4.  Eradicating Cancer Stem Cells: Concepts, Issues, and Challenges.

Authors:  Gurpreet Kaur; Praveen Sharma; Nilambra Dogra; Sandeep Singh
Journal:  Curr Treat Options Oncol       Date:  2018-03-20

Review 5.  Hepatic stem/progenitor cells and stem-cell transplantation for the treatment of liver disease.

Authors:  Sei Kakinuma; Hiromitsu Nakauchi; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2009-02-13       Impact factor: 7.527

6.  Nuclear and cytoplasmic accumulation of Ep-ICD is frequently detected in human epithelial cancers.

Authors:  Ranju Ralhan; Helen C-H He; Anthony K-C So; Satyendra C Tripathi; Manish Kumar; Md Raghibul Hasan; Jatinder Kaur; Lawrence Kashat; Christina MacMillan; Shyam Singh Chauhan; Jeremy L Freeman; Paul G Walfish
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

7.  EpCAM nuclear localization identifies aggressive thyroid cancer and is a marker for poor prognosis.

Authors:  Ranju Ralhan; Jun Cao; Terence Lim; Christina Macmillan; Jeremy L Freeman; Paul G Walfish
Journal:  BMC Cancer       Date:  2010-06-25       Impact factor: 4.430

8.  Initial activation of EpCAM cleavage via cell-to-cell contact.

Authors:  Sabine Denzel; Dorothea Maetzel; Brigitte Mack; Carola Eggert; Gabriele Bärr; Olivier Gires
Journal:  BMC Cancer       Date:  2009-11-19       Impact factor: 4.430

9.  The epithelial cell adhesion molecule EpCAM is required for epithelial morphogenesis and integrity during zebrafish epiboly and skin development.

Authors:  Krasimir Slanchev; Thomas J Carney; Marc P Stemmler; Birgit Koschorz; Adam Amsterdam; Heinz Schwarz; Matthias Hammerschmidt
Journal:  PLoS Genet       Date:  2009-07-17       Impact factor: 5.917

10.  A phase I clinical study of VB4-845: weekly intratumoral administration of an anti-EpCAM recombinant fusion protein in patients with squamous cell carcinoma of the head and neck.

Authors:  Glen C MacDonald; Michèle Rasamoelisolo; Joycelyn Entwistle; Jeannick Cizeau; Denis Bosc; Wendy Cuthbert; Mark Kowalski; Maureen Spearman; Nick Glover
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.